Advicenne (ALDVI) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.099x

Based on the latest financial reports, Advicenne (ALDVI) has a cash flow conversion efficiency ratio of -0.099x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.89 Million ≈ $2.20 Million USD) by net assets (€-19.07 Million ≈ $-22.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Advicenne defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Advicenne - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Advicenne's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Advicenne Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Advicenne ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CHARBONE HYDROGEN CORP. F:K47	0.315x
Tungray Technologies Inc Class A Ordinary Shares NASDAQ:TRSG	-0.166x
Shinpoong Pharmaceutical Co Ltd KO:019175	0.022x
Puncak Niaga Holdings Bhd KLSE:6807	0.051x
FAWER Automotive Parts Ltd Co SHE:200030	0.027x
ReGen III Corp V:GIII	0.228x
UMS Holdings Bhd KLSE:7137	0.018x
Quince Therapeutics, Inc. NASDAQ:QNCX	-0.487x

Annual Cash Flow Conversion Efficiency for Advicenne (2015–2024)

The table below shows the annual cash flow conversion efficiency of Advicenne from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Advicenne stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-19.07 Million ≈ $-22.30 Million	€-762.00K ≈ $-890.86K	0.040x	-92.01%
2023-12-31	€-11.97 Million ≈ $-13.99 Million	€-5.99 Million ≈ $-7.00 Million	0.500x	-41.93%
2022-12-31	€-10.62 Million ≈ $-12.41 Million	€-9.15 Million ≈ $-10.69 Million	0.862x	+102.13%
2021-12-31	€309.00K ≈ $361.25K	€-12.53 Million ≈ $-14.64 Million	-40.534x	-1034.15%
2020-12-31	€3.27 Million ≈ $3.83 Million	€-11.69 Million ≈ $-13.67 Million	-3.574x	-538.39%
2019-12-31	€16.92 Million ≈ $19.79 Million	€-9.47 Million ≈ $-11.08 Million	-0.560x	-62.93%
2018-12-31	€29.63 Million ≈ $34.64 Million	€-10.18 Million ≈ $-11.90 Million	-0.344x	-98.49%
2017-12-31	€33.51 Million ≈ $39.18 Million	€-5.80 Million ≈ $-6.78 Million	-0.173x	-1230.87%
2016-12-31	€-5.15 Million ≈ $-6.02 Million	€67.00K ≈ $78.33K	-0.013x	-100.81%
2015-12-31	€-1.67 Million ≈ $-1.95 Million	€-2.69 Million ≈ $-3.15 Million	1.613x	--

About Advicenne

PA:ALDVI France Biotechnology

Market Cap

$18.51 Million

€15.83 Million EUR

Market Cap Rank

#25361 Global

#414 in France

Share Price

€1.09

Change (1 day)

-0.37%

52-Week Range

€0.80 - €2.19

All Time High

€15.27